Citation: | GUO Li-min, MA Jin, CHEN Ming-wu. A comparative study of paracetamol and ibuprofen on patent ductus arteriosus in preterm infants at different stages of gestational age[J]. Chinese Journal of General Practice, 2021, 19(2): 248-251. doi: 10.16766/j.cnki.issn.1674-4152.001779 |
[1] |
MEZU-NDUBUISI O J, AGARWAL G, RAGHAVAN A, et al. Patent ductus arteriosus in premature neonates[J]. Drugs, 2012, 72(7): 907-916. doi: 10.2165/11632870-000000000-00000
|
[2] |
STOLLER J Z, DEMAURO S B, DAGLE J M, et al. Current perspectives on pathobiology of the ductus arteriosus[J]. J Clin Exp Cardiolog, 2012, 8(1): S8-001. http://www.omicsonline.org/2155-9880/pdfdownload.php?download=2155-9880-S8-001.pdf
|
[3] |
GENTILE R, STEVENSON G, DOOLEY T, et al. Pulsed doppler echocardiographic determination of time of ductal closure in normal newborn infants[J]. J Pediatr, 1981, 98(3): 443-448. doi: 10.1016/S0022-3476(81)80719-6
|
[4] |
SEMBEROVA J, SIRC J, MILETIN J, et al. Spontaneous closure of patent ductus arteriosus in infants ≤1 500 g[J]. Pediatrics, 2017, 140(2): e20164258. doi: 10.1542/peds.2016-4258
|
[5] |
BENITZ W E. Patent ductus arteriosus in preterm infants[J]. Pediatrics, 2016, 137(1): 1-6.
|
[6] |
OLGUN H, CEVIZ N, KARTAL I, et al. Repeated courses of oral ibuprofen in premature infants with patent ductus arteriosus: efficacy and safety[J]. Pediatr Neonatol, 2017, 58(1): 29-35. doi: 10.1016/j.pedneo.2015.04.017
|
[7] |
ONCEL M Y, ERDEVE O. Safety of therapeutics used in management of patent ductus arteriosus in preterm infants[J]. Curr Drug Saf, 2015, 10(2): 106-112. doi: 10.2174/1574886309999141030142847
|
[8] |
HÄRKIN P, HÄRMÄ A, AIKIO O, et al. Paracetamol accelerates closure of the ductus arteriosus after premature birth: a randomized trial[J]. J Pediatr, 2016, 177: 72-77. doi: 10.1016/j.jpeds.2016.04.066
|
[9] |
CUZZOLIN L, BARDANZELLU F, FANOS V. The dark side of ibuprofen in the treatment of patent ductus arteriosus: could paracetamol be the solution?[J]. Expert Opin Drug Metab Toxicol, 2018, 14(8): 855-868. doi: 10.1080/17425255.2018.1492550
|
[10] |
HAMMERMAN C, BIN-NUN A, MARKOVITCH E, et al. Ductal closure with paracetamol: a surprising new approach to patent ductus arteriosus treatment[J]. Pediatrics, 2011, 128(6): e1618-e1621. doi: 10.1542/peds.2011-0359
|
[11] |
ONCEL M Y, YURTTUTAN S, ERDEVE O, et al. Oral paracetamol versus oral ibuprofen in the management of patent ductus arteriosus in preterm infants: a randomized controlled trial[J]. J Pediatr, 2014, 164(3): 510-514. doi: 10.1016/j.jpeds.2013.11.008
|
[12] |
AL-LAWAMA M, ALAMMORI I, ABDELGHANI T, et al. Oral paracetamol versus oral ibuprofen for treatment of patent ductus arteriosus[J]. J Int Med Res, 2018, 46(2): 811-818. doi: 10.1177/0300060517722698
|
[13] |
BAGHERI M M, NIKNAFS P, SABSEVARI F, et al. Comparison of oral acetaminophen versus ibuprofen in premature infants with patent ductus arteriosus[J]. Iran J Pediatr, 2016, 26(4): e3975. http://www.onacademic.com/detail/journal_1000040554459710_77c9.html
|
[14] |
HUANG X, WANG F, WANG K. Paracetamol versus ibuprofen for the treatment of patent ductus arteriosus in preterm neonates: a meta-analysis of randomized controlled trials[J]. J Matern Fetal Neonatal Med, 2018, 31(16): 2216-2222. doi: 10.1080/14767058.2017.1338263
|
[15] |
OHLSSON A, SHAH P S. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants[J]. Cochrane Database Syst Rev, 2020, 1(1): CD010061. http://pdfs.semanticscholar.org/b214/b66f09949060fa95dca663f5566a8977c21e.pdf
|
[16] |
王乐, 赵婷, 李明霞. 早产儿动脉导管未闭高危因素及并发症分析[J]. 中国新生儿科杂志, 2015, 30(4): 273-276. https://cdmd.cnki.com.cn/Article/CDMD-10760-1014431911.htm
|
[17] |
高瑛, 孙岩, 王席娟, 等. 极低出生体质量儿动脉导管未闭及动脉导管再次开放的高危因素分析[J]. 新乡医学院学报, 2017, 34(7): 574-578. https://www.cnki.com.cn/Article/CJFDTOTAL-XXYX201707006.htm
|
[18] |
陈超, 张兰, 李登峰, 等. 动脉导管内径对早产儿有血流动力学改变的动脉导管未闭并发症影响分析[J]. 中华全科医学, 2020, 18(2): 191-193, 223. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY202002008.htm
|
[19] |
MADELENEAU D, AUBELLE M S, PIERRON C, et al. Efficacy of a first course of Ibuprofen for patent ductus arteriosus closure in extremely preterm newborns according to their gestational age-specific Z-score for birth weight[J]. PLoS One, 2015, 10(4): e0124804. doi: 10.1371/journal.pone.0124804
|
[20] |
杨波, 陈洋, 高翔羽, 等. 影响早产儿症状性动脉导管未闭发生及药物干预效果的相关因素分析[J]. 中华心脏与心律电子杂志, 2015, 3(1): 28-34.
|
[21] |
EL-MASHAD A E, EL-MAHDY H, EL AMROUSY D, et al. Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates[J]. Eur J Pediatr, 2017, 176(2): 233-240. doi: 10.1007/s00431-016-2830-7
|
[22] |
OHLSSON A, WALIA R, SHAH S S. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants[J]. Cochrane Database Syst Rev, 2020, 2(2): CD003481. http://pdfs.semanticscholar.org/83e7/3f0de5007b2e946538a7d58f96116c554e9c.pdf
|
[23] |
ONCEL M Y, ERAS Z, URAS N, et al. Neurodevelopmental outcomes of preterm infants treated with oral paracetamol versus ibuprofen for patent ductus arteriosus[J]. Am J Perinatol, 2017, 34(12): 1185-1189. doi: 10.1055/s-0037-1601564
|
[24] |
EL-FARRASH R A, EL SHIMY M S, EL-SAKKA A S, et al. Efficacy and safety of oral paracetamol versus oral ibuprofen for closure of patent ductus arteriosus in preterm infants: a randomized controlled trial[J]. J Matern Fetal Neonatal Med, 2019, 32(21): 3647-3654. doi: 10.1080/14767058.2018.1470235
|
[25] |
KARABULUT B, PAYTONCU S. Efficacy and safety of oral paracetamol vs. oral ibuprofen in the treatment of symptomatic patent ductus arteriosus in premature infants[J]. Paediatr Drugs, 2019, 21(2): 113-121. doi: 10.1007/s40272-019-00331-z
|